When significant skin and soft tissue are lost, restoring coverage becomes an important part of treatment. Depending on the size, depth, location, and cause of the defect, clinicians may consider several approaches, including autologous skin grafting and biologic materials derived from human tissue.

An amniotic skin graft belongs to a different category from a conventional skin graft. Understanding that distinction is important because the terms “graft” and “skin substitute” are sometimes used broadly, even though the materials and their clinical roles can be quite different.

What Is an Amniotic Skin Graft?

An amniotic skin graft is a medical material derived from human amniotic tissue and prepared for a specific clinical application. Unlike an autologous skin graft, it is not a piece of the patient's own skin transferred from one body site to another.

Amniotic tissue has been studied for decades in regenerative medicine. Its structural properties and extracellular matrix have generated interest in applications involving tissue coverage and repair.

The term “amniotic skin graft” should not, however, be interpreted as meaning that the material is equivalent to living skin. Its biological characteristics and clinical role differ from those of a conventional autologous graft.

Amniotic Graft vs. Traditional Skin Graft

A traditional skin graft typically involves harvesting skin from a donor site on the patient's body and transferring it to the area requiring coverage.

Two commonly recognized forms are split-thickness and full-thickness skin grafts. The choice depends on factors such as the defect, anatomical location, required durability, and reconstructive objective.

An amniotic graft takes a different approach. Because the material is derived from placental tissue rather than harvested from the patient's own skin, it does not create a conventional skin-graft donor site.

That difference can be clinically relevant. A traditional graft requires the patient to have an appropriate donor area and creates an additional site that must be managed during recovery. An amniotic-derived material may provide another option when clinicians are considering biologic coverage rather than transferring the patient's own skin.

Neither approach is universally preferable. The appropriate choice depends on the clinical situation and the intended outcome.

Where Does a Skin Substitute Fit?

Skin substitute is a broad term used for materials designed to provide coverage, protection, structural support, or other functions in the management of tissue defects.

Skin substitutes can be biological, synthetic, or composite materials. Some are designed primarily as temporary coverings, while others provide a scaffold intended to support tissue regeneration.

This makes the term broader than “amniotic graft.” An amniotic-derived material may be considered a biologic substitute in certain contexts, but not every skin substitute contains amniotic tissue.

For clinicians, distinguishing these categories helps prevent an important misconception: a skin substitute is not necessarily an artificial replacement for every function of human skin.

Why Temporary Coverage Can Matter

A major goal in managing a tissue defect is establishing an environment in which the wound can progress toward closure.

Depending on the clinical situation, temporary biologic coverage may help protect exposed tissue and provide an appropriate interface while the treatment plan progresses.

This is different from saying that an amniotic material permanently replaces lost skin.

Permanent coverage may ultimately require the patient's own tissue, surgical reconstruction, or another definitive procedure. The role of an amniotic material depends on the specific indication and the product's intended use.

Potential Clinical Applications

Amniotic-derived materials have been investigated in several areas of medicine, including chronic wound management, burns, ophthalmology, and reconstructive applications.

Research into chronic wounds has produced encouraging findings for some human amniotic membrane preparations. A 2026 systematic review and meta-analysis of randomized controlled trials reported higher complete-healing rates with human amniotic membrane treatment compared with conventional treatment in chronic ulcers, while also noting limitations in the available evidence.

Research in burn care has also investigated amniotic membrane applications, including their potential role in wound coverage and healing.

These findings demonstrate why amniotic tissue continues to attract clinical interest, but they should not be interpreted as proof that every amniotic product has identical effects.

Factors That Influence the Choice of Graft

The decision to use an amniotic graft, an autologous skin graft, or another skin substitute should be based on the individual clinical situation.

Important considerations can include:

• Size and depth of the tissue defect
• Anatomical location
• Condition of the wound bed
• Availability of suitable donor skin
• Need for temporary or definitive coverage
• Patient-specific healing considerations
• Expected functional and cosmetic requirements
• Evidence supporting the proposed material and indication

For reconstructive procedures, function can be just as important as closure. Areas surrounding joints, the hands, face, and other anatomically sensitive locations may have specific requirements for flexibility, durability, sensation, or appearance.

Evidence Matters More Than the Category Name

A product's classification alone cannot establish how well it will perform in a particular clinical situation.

When evaluating an amniotic skin graft or another skin substitute, clinicians should look at evidence relating to the specific material and intended application. Published studies can differ in their patient populations, wound types, treatment protocols, follow-up periods, and outcome measures.

This is particularly important when comparing biologic products. Evidence associated with one tissue preparation should not automatically be generalized to every product derived from amniotic tissue.

The Future of Biologic Skin Coverage

Advances in regenerative medicine continue to broaden the range of materials available for tissue coverage. Amniotic-derived products are part of this wider development, alongside other biological and engineered skin substitutes.

The most useful way to view an amniotic skin graft is not as a universal replacement for traditional grafting. Instead, it represents one type of biologic material that may have a role in carefully selected clinical situations.

Understanding the difference between an amniotic graft, an autologous skin graft, and a broader skin substitute category allows clinicians to evaluate each option according to its actual characteristics, intended purpose, and supporting evidence.